DOI:

Complete removal of extensive right coronary artery thrombus by the use of an aspiration catheter to facilitate primary angioplasty

Ajay K. Jain, BSC, MRCP; R. Andrew Archbold*, MD, MRCP

A 67 year old man with a one-hour history of chest pain due to acute inferior ST elevation myocardial infarction underwent coronary angiography after treatment with aspirin 300 mg, clopidogrel 600 mg, and a weight-adjusted abciximab bolus. The culprit lesion was a proximal occlusion of the right coronary artery (panel A). Passage of a 0.014” angioplasty wire through the occlusion restored TIMI I antegrade flow, which revealed a severe stenosis in the proximal right coronary artery (RCA) in association with a large thrombus extending to the acute margin (panel B). Angiographically visible thrombus was completely removed by the use of an aspiration catheter (Export Catheter, Medtronic, USA) (panel C). The stenosis was then stented with a 5.0 x 20 mm Liberte™ (Boston Scientific, USA) stent with no angiographic evidence of distal embolisation or no-reflow (panel D). The patient was discharged 48 hours later.

A large thrombus burden in the infarct-related artery poses technical and therapeutic challenges during percutaneous coronary intervention. Furthermore, its presence is associated with adverse angiographic and clinical outcomes. Conventional management employs combination antiplatelet therapy that includes an infusion of a glycoprotein IIb/IIIa receptor inhibitor, but the role of mechanical thrombectomy devices remains contentious. These images demonstrate that the use of an aspiration catheter can dramatically reduce thrombus load in these patients. This facilitates the procedure through better visualisation of the lesion, allowing appropriate stent selection, and it may reduce the propensity to no-reflow. Whether or not there is a clinical advantage from the use of such devices, however, remains to be determined.

Volume 3 Number 1
May 22, 2007
Volume 3 Number 1
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-25-00053 Jan 5, 2026
The quiescent volcanoes that don't harm anymore
Prati F and Biccirè F
free

Editorial

10.4244/EIJ-D-25-01153 Jan 5, 2026
Computed tomography angiography-derived microvascular resistance: is less always more?
Gallinoro E and Barbato E
free

Editorial

10.4244/EIJ-E-25-00051 Jan 5, 2026
QFR in clinical practice: raising the bar for quality and reproducibility
Lansky A
free

Viewpoint

10.4244/EIJ-D-25-01167 Jan 5, 2026
High-risk plaques: intervene early or hold the line?
Mintz G and Collet C
free

Expert Review

10.4244/EIJ-D-25-00263 Jan 5, 2026
Endomyocardial biopsy
Fabris E et al
free

Original Research

10.4244/EIJ-D-25-00648 Jan 5, 2026
Long-term clinical outcomes of non-culprit plaque rupture in STEMI
Zhao J et al

Original Research

10.4244/EIJ-D-25-00671 Jan 5, 2026
Non-invasive assessment of microcirculatory resistance by coronary computed tomography angiography
Deng D et al

Original Research

10.4244/EIJ-D-25-00668 Jan 5, 2026
Repeatability and quality assessment of QFR in the FAVOR III Europe trial: the REPEAT-QFR study
Kristensen S et al
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved